Skip to main content
Clinical Trials/IRCT20130812014333N164
IRCT20130812014333N164CompletedPhase 2

Investigation of the effects of the exosomes derived from placental mesenchymal stem cells on the oxygen saturation and biological markers of patients with COVID-19

Kermanshah University of Medical Sciences0 sites8 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
8

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
no limit to no limit (—)
Sex
All

Inclusion Criteria

  • Infected patients with Corona virus based on CRISPR test (PCR)
  • Diagnosis of acute respiratory syndrome according to Berlin criteria
  • Requires oxygenation or confirmed pneumonia by radiologically or CT
  • Oxygen uptake concentration
  • Progression of of pulmonary edema more than 50% within 24-48 hours
  • Mild to moderate pneumonia caused by a new coronavirus

Exclusion Criteria

  • Serious underlying illness or psychosis
  • Co-infection with HIV, tuberculosis, influenza virus, adenovirus and other viral respiratory infections
  • Liver or kidney SOFA score more than 3

Investigators

Similar Trials